Schwartz B S, Stewart W F, Todd A C, Links J M
Department of Environmental Health Sciences, Johns Hopkins School of Hygiene and Public Health, Baltimore, MD 21205, USA.
Occup Environ Med. 1999 Jan;56(1):22-9. doi: 10.1136/oem.56.1.22.
To identify predictors of tibial and dimercaptosuccinic acid (DMSA) chelatable lead in 543 organolead manufacturing workers with past exposure to organic and inorganic lead.
In this cross sectional study, tibial lead (by 109Cd K-shell x ray fluorescence), DMSA chelatable lead (4 hour urinary lead excretion after oral administration of 10 mg/kg), and several exposure measures were obtained on study participants, mean (SD) age 57.6 (7.6) years.
Tibial lead concentrations ranged from -1.6 to 52.0 micrograms lead/g bone mineral, with a mean (SD) of 14.4 (9.3) micrograms/g. DMSA chelatable lead ranged from 1.2 to 136 micrograms, with a mean (SD) of 19.3 (17.2) micrograms. In a multiple linear regression model of tibial lead, age (p < 0.01), duration of exposure (p < 0.01), current (p < 0.01) and past (p = 0.05) cigarette smoking, and diabetes (p = 0.01) were all independent positive predictors, whereas height (p = 0.03), and exercise inducing sweating (p = 0.04) were both negative predictors. The final regression model accounted for 31% of the variance in tibial lead concentrations; 27% was explained by age and duration of exposure alone. DMSA chelatable lead was directly associated with tibial lead (p = 0.01), cumulative exposure to inorganic lead (y.microgram/m3, p = 0.01), current smoking (p < 0.01), and weight (p < 0.01), and negatively associated with diabetes (p = 0.02). The final model accounted for 11% of the variance in chelatable lead. When blood lead was added to this model of DMSA chelatable lead, tibial lead, cumulative exposure to inorganic lead, and diabetes were no longer significant; blood lead accounted for the largest proportion of variance (p < 0.001); and the total model r2 increased to 19%.
The low proportions of variance explained in models of both tibial and chelatable lead suggest that other factors are involved in the deposition of lead in bone and soft tissue. In epidemiological studies of the health effects of lead, evaluation of associations with both these measures may allow inferences to be made about whether health effects are likely to be recent, and thus potentially reversible, or chronic, and thus possibly irreversible. The data also provide direct evidence that in men the total amount of lead in the body that is bioavailable declines with age.
在543名曾接触有机铅和无机铅的有机铅制造工人中,确定胫骨铅和二巯基丁二酸(DMSA)可螯合铅的预测因素。
在这项横断面研究中,对研究参与者(平均[标准差]年龄57.6[7.6]岁)进行了胫骨铅(通过109Cd K层X射线荧光法测定)、DMSA可螯合铅(口服10mg/kg后4小时尿铅排泄量)以及几种接触量指标的检测。
胫骨铅浓度范围为-1.6至52.0微克铅/克骨矿物质,平均(标准差)为14.4(9.3)微克/克。DMSA可螯合铅范围为1.2至136微克,平均(标准差)为19.3(17.2)微克。在胫骨铅的多元线性回归模型中,年龄(p<0.01)、接触持续时间(p<0.01)、当前(p<0.01)和既往(p = 0.05)吸烟以及糖尿病(p = 0.01)均为独立的正向预测因素,而身高(p = 0.03)和运动引起出汗(p = 0.04)均为负向预测因素。最终回归模型解释了胫骨铅浓度31%的方差;仅年龄和接触持续时间就解释了27%。DMSA可螯合铅与胫骨铅(p = 0.01)、无机铅累积接触量(y.微克/立方米,p = 0.01)、当前吸烟(p<0.01)和体重(p<0.01)直接相关,与糖尿病(p = 0.02)呈负相关。最终模型解释了可螯合铅11%的方差。当将血铅添加到这个DMSA可螯合铅模型中时,胫骨铅、无机铅累积接触量和糖尿病不再具有显著性;血铅解释的方差比例最大(p<0.001);总模型r2增加到19%。
胫骨铅和可螯合铅模型中解释的低方差比例表明,其他因素参与了铅在骨骼和软组织中的沉积。在铅对健康影响的流行病学研究中,对这两种指标关联的评估可能有助于推断健康影响是近期的,因此可能是可逆的,还是慢性的,因此可能是不可逆的。数据还提供了直接证据,表明在男性中,体内生物可利用的铅总量随年龄增长而下降。